Capital, Canada and the USA in focus of the Lift Cannabis Business Conference

0
117

This press release contains multimedia. View the full version here: https://www.businesswire.com/news/home/20211208005677/en/

The documentary trailer “The Sentence of Michael Thompson” received a silver Clio at the Clio Cannabis Awards 2021, the most prestigious program for recognizing marketing and communication work. (Graphic: Business Wire)

Building on Clio’s longstanding reputation for establishing world-class programs that recognize creative excellence in a variety of specialized industries, the Clio Cannabis Awards – now in its third year – honor work and talent that creates a better understanding of a rapidly growing industry.

“It is an honor for our efforts to be recognized by such a prestigious platform for the second time in a row. Highest Recognition for ‘The Sentence of Michael Thompson’ is very special as social justice and social justice are at the core of the company’s mission and the film aims to help people understand the severity of the effects of injustice on the lives of people Really understand people adversely affected by the war on drugs, “said Cory Rothschild, SVP of Marketing.

Chima Enyia, SEED’s EVP, added: “We appreciate everyone involved – Michael Thompson, his family, partners in Restorative Justice and our staff – in making this film. More than 40,000 Americans remain in jail for cannabis offenses, and there is much more work to be done to redress the wrongs of The War on Drugs, we are focused on using our platform and influence to raise awareness of Michael’s story to ensure talks on legalizing pardons for those currently incarcerated for cannabis offenses and social justice in the cannabis industry. ”

On June 10th, Cresco released the trailer for “The Sentence of Michael Thompson,” a short documentary film about the story of Michigan’s longest serving nonviolent offender. In January of that year, Thompson was pardoned for serving a 60-year sentence in Muskegon Correctional Center, Michigan, for selling 3 pounds of cannabis to a police informant in 1994. The trailer brought in the Silver Clio for film & video. The documentary will be released in 2022.

Launched in August for National Wellness Month, Wonder Wellness has developed a unique audio collection designed to help listeners focus, relax, laugh, or sleep on the experiences created by its rubber and mini products to be delivered. The Discover Some Wonder initiative was named the winner of the shortlist for Digital & Mobile.

In time for this year’s 420 holiday, Sunnyside released the results of a nationwide survey that identified changing beliefs and behaviors regarding cannabis use and translated them into accessible messages about the plant’s functional benefits for every type of consumer. The # Wayto420 campaign was nominated in the Public Relations category.

To view the full gallery of the winning work, visit www.cliocannabisawards.com.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated, multi-state cannabis operators in the United States with the aim of normalizing and professionalizing the cannabis industry. Cresco Labs takes a consumer packaging (“CPG”) approach and is the largest wholesaler of branded cannabis products in the United States including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, the national pharmacy brand of Cresco Labs, is a wellness-focused retailer founded to create trust, education and convenience for both existing and new cannabis users. Cresco Labs is aware that the cannabis industry is well on its way to becoming one of the premier workplaces in the country and runs the industry’s largest social justice and educational development initiative, SEED, which was created to ensure that all members society of the skills, knowledge, and opportunity to work and do business in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Forward-Looking Statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws and may also contain statements that are “forward-looking statements” within the meaning of the safe harbor of the United States Private Securities Litigation Reform Act of. May represent 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current status, but instead only represent the company’s views regarding future events, plans or goals, many of which are inherently uncertain and beyond control of the company. In general, such forward-looking information or forward-looking statements may be made through the use of forward-looking terminology such as “may”, “will”, “should”, “could”, “would”, “expect”, “plan”, “anticipate”, “believe” ‘,’ estimate ‘,’ project ‘,’ predict ‘,’ potential ‘or’ continue ‘or the negative of these forms or other comparable terms. The company’s forward-looking statements involve known and unknown risks, uncertainties, and other factors that could cause actual results, performance or accomplishments to differ materially from the future results, performance or achievements expressed or implied in the forward-looking statements including, but not limited to, the risks identified under “Risk Factors” on the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021 and other documents filed by the Company with Canadian Securities and Markets have been submitted, are explained; and other factors, many of which are beyond the control of the company. Readers are cautioned that the list of factors above is not exhaustive. Because of these uncertainties, you should not place undue reliance on any forward-looking statements made by the company. No representations are made as to the future trading price or volume of Cresco Labs shares or the company’s financial performance in future financial years. The company does not intend to update these factors or to publicly announce the result of changes to any forward-looking statements contained herein, whether as a result of new information, a future event, or otherwise. Unless otherwise stated, this press release is as of the date of this press release. The publication of this press release does not imply that the affairs of the company have not changed after the date of this press release or that it creates an obligation or obligation to update or supplement any information in this press release or otherwise.

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investor Relations:
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com